Microparticles and Exosomes in Gynecologic Neoplasias

ABSTRACT

This review presents an overview of the functions of microparticles and exosomes in gynecologic neoplasias. Growing evidence suggests that vesicles released from cancer cells in gynecologic malignancies contribute to the hypercoagulable state of these patients and contribute to tumor progression by suppressing the immune system, facilitating extracellular matrix degradation and removal of cytostatics from the tumor cell. Exosomes from ovarian carcinoma cells were shown to be present in peripheral blood and to augment tumor growth, suggesting that these vesicles directly support growth of tumor cells.

KEYWORDS

Microparticle - exosome - cancer - gynecologic malignancy

REFERENCES

• 1 Toth B, Lok C A, Böing A et al. Microparticles and exosomes: impact on normal and complicated pregnancy.  Am J Reprod Immunol. 2007;  58(5) 389-402
• 2 Dvorak H F, Quay S C, Orenstein N S et al. Tumor shedding and coagulation.  Science. 1981;  212(4497) 923-924
• 3 Dvorak H F, Van DeWater L, Bitzer A M et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.  Cancer Res. 1983;  43(9) 4434-4442
• 4 Kakkar A K, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson R C. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor.  Lancet. 1995;  346(8981) 1004-1005
• 5 Goyal D, Choudhury A, Lip G Y. Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies.  Curr Opin Obstet Gynecol. 2005;  17(1) 13-20
• 6 Satoh T, Matsumoto K, Uno K et al. Silent venous thromboembolism before treatment in endometrial cancer and the risk factors.  Br J Cancer. 2008;  99(7) 1034-1039
• 7 Uno K, Homma S, Satoh T et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer.  Br J Cancer. 2007;  96(2) 290-295
• 8 Tesselaar M E, Romijn F P, Van Der Linden I K, Prins F A, Bertina R M, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?.  J Thromb Haemost. 2007;  5(3) 520-527
• 9 Yokota N, Koizume S, Miyagi E et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.  Br J Cancer. 2009;  101(12) 2023-2029
• 10 Keller S, König A K, Marmé F et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.  Cancer Lett. 2009;  278(1) 73-81
• 11 Liu C, Yu S, Zinn K et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.  J Immunol. 2006;  176(3) 1375-1385
• 12 Dolo V, Pizzurro P, Ginestra A, Vittorelli M L. Inhibitory effects of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-beta antibodies.  J Submicrosc Cytol Pathol. 1995;  27(4) 535-541
• 13 Abrahams V M, Straszewski S L, Kamsteeg M et al. Epithelial ovarian cancer cells secrete functional Fas ligand.  Cancer Res. 2003;  63(17) 5573-5581
• 14 Frängsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.  Mol Hum Reprod. 2005;  11(1) 35-41
• 15 Taylor D D, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling.  J Immunol. 2006;  176(3) 1534-1542
• 16 Martin L P, Schilder R J. Management of recurrent ovarian carcinoma: current status and future directions.  Semin Oncol. 2009;  36(2) 112-125
• 17 Hamilton K K, Hattori R, Esmon C T, Sims P J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.  J Biol Chem. 1990;  265(7) 3809-3814
• 18 Safaei R, Larson B J, Cheng T C et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells.  Mol Cancer Ther. 2005;  4(10) 1595-1604
• 19 Dolo V, D'Ascenzo S, Violini S et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.  Clin Exp Metastasis. 1999;  17(2) 131-140
• 20 Graves L E, Ariztia E V, Navari J R, Matzel H J, Stack M S, Fishman D A. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.  Cancer Res. 2004;  64(19) 7045-7049
• 21 Runz S, Keller S, Rupp C et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.  Gynecol Oncol. 2007;  107(3) 563-571
• 22 Dolo V, Ginestra A, Ghersi G, Nagase H, Vittorelli M L. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities.  J Submicrosc Cytol Pathol. 1994;  26(2) 173-180
• 23 Ginestra A, Miceli D, Dolo V, Romano F M, Vittorelli M L. Membrane vesicles in ovarian cancer fluids: a new potential marker.  Anticancer Res. 1999;  19(4C) 3439-3445
• 24 Stoeck A, Keller S, Riedle S et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44.  Biochem J. 2006;  393(Pt 3) 609-618
• 25 Gutwein P, Stoeck A, Riedle S et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells.  Clin Cancer Res. 2005;  11(7) 2492-2501
• 26 Taylor D D, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.  Gynecol Oncol. 2008;  110(1) 13-21
• 27 Taylor D D, Gercel-Taylor C, Parker L P. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.  Gynecol Oncol. 2009;  115(1) 112-120
• 28 Li J, Sherman-Baust C A, Tsai-Turton M, Bristow R E, Roden R B, Morin P J. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.  BMC Cancer. 2009;  9 244
• 29 Ochieng J, Pratap S, Khatua A K, Sakwe A M. Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes.  Exp Cell Res. 2009;  315(11) 1875-1888
• 30 Al-Nedawi K, Meehan B, Micallef J et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.  Nat Cell Biol. 2008;  10(5) 619-624
• 31 Skog J, Würdinger T, van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.  Nat Cell Biol. 2008;  10(12) 1470-1476